Location: Home
  • search
  • go
  • Relate News
  • 6/16/2025CARsgen Delivers Deep Responses with CT071 in Newly Diagnosed Multiple...
  • 6/16/2025Legend Reportedly Disbands China Sales & Marketing Team Amid Shifts
  • 6/16/2025Xuanzhu Prepares for HKSE Main Board Listing
  • 6/16/2025Merck's Keytruda Gains NMPA Approval in China for Advanced Liver Cance...
  • 6/16/2025Teva, Fosun Pharma Partner to Develop Immuno-Oncology Therapy
  • 6/16/2025NMPA Seeks Comments on Initiative to Optimize Clinical Trial Review Pr...
  • 6/16/2025Lupin Partners with Sino Universal Pharma to Expand Access to Tiotropi...
  • 6/14/2025Keymed Biosciences' BsAb Shows Promise in Autoimmune Hemolytic Anemia
  • 6/14/2025Tianjin Slaps CNY 362M Fine for Drug Price-Fixing Scheme
  • 6/13/2025Kelun Cleared for Clinical Trial of SKB315 and Tagitanlimab Combo in C...
  • 6/13/2025Nona and Visterra Partner to Advance Next-Gen Biotherapeutics for Immu...
  • 6/13/2025AstraZeneca Enters Strategic Deal with CSPC Pharma Focused on AI-enabl...
  • 6/13/2025AB‑RayBio Secures Multi‑Million CNY Angel Investment
  • 6/13/2025Abbisko Therapeutics' Pimicotinib Earns NMPA Nod for TGCT NDA Review
  • 6/13/2025China Issues 2025 Action Plan to Combat Malpractice in Pharma Procure...
  • 6/13/2025Recent Executive Moves
  • 6/12/2025InnoVec Raises Tens of Millions in Series A+ to Accelerate Gene Therap...
  • 6/12/2025Cloudbreak Advances Ophthalmic Pipeline, Pursues Hong Kong IPO
  • 6/12/2025Dizal to Showcase Breakthrough Data on Hematologic Oncology Assets at ...
  • 6/12/2025CF PharmaTech Files for Hong Kong IPO
  • 6/12/2025Hengrui Advances DLL3‑Targeting ADC SHR‑4849 with Phase II China Tri...
  • 6/12/2025Viatris Wins NMPA Approval for Once‑Daily Nebulized COPD Therapy Yupe...
  • 6/12/2025China's AI Healthcare Market (Part I): Growth Trends, Drivers, and APA...
  • 6/12/2025China's AI Healthcare Market (Part II): Opportunities and Strategies f...
  • 6/11/20253Sbio Powers Ahead in PD-1/VEGF Bispecific Race with Impressive Phase ...
  • 6/11/2025Ligachem Inks Dual ADC Licensing Deals with CSPC Subsidiary Novarock
  • 6/11/2025JW Pharma Wins China Approval for Ertapenem Injection
  • 6/11/2025MediLink Therapeutics Lines Up Major Banks for Hong Kong IPO Push
  • 6/10/2025GenEditBio Doses First Patient in World’s First In Vivo CRISPR Trial ...
  • 6/10/2025Innogen Pharma Files for Hong Kong Listing, Accelerates Pipeline Devel...
  • Page:9/780 Total number of articles:23377: [First][<<] [7] [8] [9] [10] [11] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group